HCV treatment--no more room for interferonologists?

@article{Drenth2013HCVTM,
  title={HCV treatment--no more room for interferonologists?},
  author={Joost P. H. Drenth},
  journal={The New England journal of medicine},
  year={2013},
  volume={368 20},
  pages={1931-2}
}
The landscape of therapy for hepatitis C virus (HCV) infection is changing rapidly. Until recently, the standard of care for HCV infection was a combination of peginterferon and ribavirin. Our increased understanding of the basic biology of HCV led to the identification of specific proteins involved in the replication of the virus. These proteins can be targeted by protease and polymerase inhibitors. Two years ago, the advent of protease inhibitors, such as telaprevir and boceprevir, profoundly… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 27 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…